weight loss injection liraglutide semaglutide
Many people reach a point in losing weight where the usual advice stops working. The diet is clean and the exercise is consistent, but the weight isn’t shifting the way it should. That gap between effort and results often comes down to biology rather than discipline – hormonal factors can actively work against weight loss, and no amount of lifestyle adjustment alone is always enough to overcome them. That’s where weight loss injections, sometimes called slimming medicine or weight loss pens, come in: prescription-grade medications such as Semaglutide (Ozempic/Wegovy), Liraglutide (Saxenda), Tirzepatide (Mounjaro), and Retatrutide that work at a hormonal level to regulate appetite, slow gastric emptying, and improve metabolic function, now medically available in Bangkok under full medical supervision at H.U.M. Clinic.
Most people assume weight gain or stalled progress is simply about eating too much or not exercising enough. The reality is often more complex.
  • Insulin resistance: the body stores fat instead of burning it efficiently.
  • Hormonal imbalances: low testosterone, high cortisol, or thyroid issues can slow metabolism and increase cravings.
  • Chronic stress and sleep deprivation: both affect how the body processes food and stores fat.
  • Calorie restriction burnout: eating too little for too long leads to low energy, binge-eating cycles, and stalled results.
When the body isn’t cooperating, willpower alone cannot override biology – this is where medically supervised weight loss injections step in.
The term is used loosely, but weight loss injections are prescription medications that work through the body’s own hormonal pathways – specifically the incretin system, which regulates hunger, gastric emptying, and blood sugar. Every treatment plan at H.U.M. Clinic is customized after a consultation and full body analysis.
  • GLP-1 receptor agonists: mimic glucagon-like peptide-1, a hormone released after eating that signals fullness to the brain, slows digestion, and reduces caloric intake. Semaglutide and liraglutide fall here.
  • Dual GIP/GLP-1 receptor agonists: act on two incretin hormones simultaneously (GLP-1 and GIP), producing stronger appetite suppression and greater metabolic effects. Tirzepatide (Mounjaro) is the primary example.
  • Triple hormone receptor agonists: retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously, and represents the newest generation of obesity treatment.
  • Higher efficacy: injections deliver medication directly into the bloodstream through the fatty layer under the skin, ensuring consistent, stable absorption throughout the day.
  • Longer-lasting effects: some injections, like Semaglutide, require only weekly administration, offering convenience over daily pills.
  • Less frequent dosing: reduces the need for daily medication adherence, making it easier to stay on track.
As regulated medications, all of these require a prescription from a licensed doctor. The right choice depends entirely on health history, body composition, and goals – which is why medical assessment always comes first.
weight loss injection liraglutide
Injections enter the bloodstream directly and work in a stable, predictable manner; pills must pass through the digestive system first, so their absorption can vary with food intake, stomach acidity, and individual metabolism.

Comparison Table
AspectWeight Loss InjectionsWeight Loss Pills
AbsorptionDirect into bloodstreamThrough digestive system
ConsistencyStable and predictableVaries day to day
EffectivenessHigher overall resultsModerate results
MechanismControls appetite and fullnessFat blocking or appetite suppression
Side EffectsMostly mild and temporaryMore digestive or stimulant effects
Long-term ResultsEasier to maintainHigher chance of weight regain
A convenient, self-administered weight loss pen delivers small doses of GLP-1 (or dual/triple-hormone) medication to help suppress appetite and regulate blood sugar. Several medications are actively prescribed at licensed clinics in Bangkok:

Semaglutide is a GLP-1 receptor agonist administered once weekly by subcutaneous injection, available under two brand names. Wegovy is FDA-approved specifically for chronic weight management in adults with obesity or overweight with a related health condition. Ozempic is approved for type 2 diabetes management and commonly prescribed off-label for weight loss. Both contain the same active compound; clinical trials demonstrated meaningful body weight reductions sustained over 68 weeks when combined with lifestyle modifications, with some patients losing up to 15% of body weight in a year. Semaglutide suits patients who prefer once-weekly dosing, those with blood sugar dysregulation, and those new to GLP-1 therapy.

Tirzepatide is the dual-action option, activating both GIP and GLP-1 receptors simultaneously for stronger appetite suppression than GLP-1 alone. The brain receives a stronger, more sustained signal to stop eating while food moves through the stomach more slowly, reducing overall caloric intake. The SURMOUNT-1 phase 3 trial, published in the New England Journal of Medicine, found that participants on the 15 mg dose achieved an average body weight reduction of 22.5% over 72 weeks – among the strongest results documented for a non-surgical weight intervention. Tirzepatide received regulatory approval in Thailand in 2024 and is available at licensed clinics including H.U.M. Clinic Bangkok.

Retatrutide is an investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously – the next generation of obesity treatment. Unlike semaglutide, which targets GLP-1 alone, and tirzepatide, which targets GLP-1 and GIP, retatrutide activates three metabolic pathways at once. Early clinical trials have demonstrated remarkable weight loss outcomes, making it one of the most promising options for patients who want the strongest available medical option after a full evaluation.

Saxenda (liraglutide) is an older GLP-1 receptor agonist administered as a daily injection, with a well-established safety profile built over years of clinical use and specific Thai FDA approval for weight loss. Clinical trials showed an average weight loss of 5-10% of body weight over a year when combined with a reduced-calorie diet and increased physical activity. Daily dosing makes it less convenient than once-weekly alternatives, but it remains clinically appropriate for patients who require more gradual titration or have specific medical considerations that favor a longer-established treatment record.

Dulaglutide (Trulicity) is another once-weekly injection approved for diabetes management and available at hospitals via an endocrinologist. For patients who prefer not to inject daily or weekly, oral semaglutide (Rybelsus) offers a once-daily pill alternative – the only GLP-1 analog available in pill form. Lipotropic injections use amino acids and vitamins to support liver function and fat metabolism, and are often used alongside GLP-1 therapy as a complementary option rather than a standalone weight loss treatment.

Note on comparison: these are not ranked by superiority. Patient profile, health history, and medical assessment determine suitability. A doctor’s evaluation is the only reliable basis for choosing between them.

Many patients also report improved energy levels and better overall health alongside the weight loss itself, particularly when the medication is combined with other lifestyle changes.

Reported Average Weight Loss by Medication (Clinical Trial Data)
MedicationAverage Weight LossStudy Duration
Tirzepatide (Mounjaro)Up to 22.5% of body weight72 weeks (SURMOUNT-1)
Semaglutide (Wegovy)Up to 15% of body weight68 weeks
Semaglutide (Ozempic, 1mg/week)~5% of body weight30 weeks
Liraglutide (Saxenda)5-10% of body weight1 year
This is what happen when you have used weight loss injection, Semaglutide, Liraglutide
  • 1-2 weeks: appetite reduction typically begins.
  • 4-8 weeks: visible weight changes generally become apparent.
  • 3-6 months: clinically meaningful results; most patients at or near their target dose.
  • 6-12 months: sustained weight loss; treatment and lifestyle integration stabilized.
Combining injections with healthier habits leads to sustainable results without extreme dieting.

These are population-level timelines. Individual response varies based on starting weight, dose, metabolic factors, and lifestyle changes made alongside treatment.

The generally accepted clinical criteria include:
  • BMI of 30 or above (obesity classification), or BMI of 27 or above with at least one weight-related health condition such as hypertension, type 2 diabetes, or dyslipidemia
  • A documented history of inadequate response to lifestyle-based weight loss approaches
  • Insulin resistance or prediabetes
  • A long-term weight plateau despite consistent diet and exercise effort
  • Constant hunger or cravings that suggest an underlying hormonal cause
  • A condition such as PCOS that affects weight
A doctor’s evaluation helps determine suitability and the safest approach for your situation. Weight often returns after stopping these medications without ongoing lifestyle changes in place, so they should be viewed as part of a longer-term health strategy rather than a quick fix.
The most common side effects of weight loss injections are gastrointestinal: nausea, loose stools, constipation, and occasional vomiting. These are most pronounced during the initial dose-escalation period. Titration protocols, where doses increase gradually over weeks, exist precisely to reduce this burden – most patients find GI symptoms ease significantly once they reach a stable dose.
Combining H.U.M. Clinic’s original guidance with current FDA prescribing information for tirzepatide and semaglutide, the following should be reviewed with a doctor before starting treatment:
  • Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) – contraindicated across this entire medication class; carries an FDA boxed warning for thyroid C-cell tumor risk based on rodent studies.
  • Known hypersensitivity to the medication or any component of the formulation, including prior anaphylaxis or angioedema.
  • Pregnancy or breastfeeding, or actively trying to become pregnant – not recommended due to insufficient safety data.
  • History of pancreatitis – GLP-1 receptor agonists have been associated with acute pancreatitis, including rare hemorrhagic or necrotizing cases, so a prior episode warrants extra caution and closer monitoring.
  • Serious gastrointestinal conditions, including gastroparesis or severe inflammatory bowel disease.
  • Kidney (renal) impairment – may require dose modification, use with caution as it can affect medication metabolism.

This list is not a substitute for a medical consultation. At H.U.M. Clinic, every new weight-loss injection patient completes a full health-history screening and consultation before a prescription is issued.

The program begins with a proper clinical assessment: health history, body composition analysis, and blood work where indicated, to match the right medication to your specific physiology.

Doses start low and increase on a structured schedule, typically in 2.5 mg increments every four weeks for tirzepatide. This medically established approach reduces side effects while allowing the body to adapt, and is carefully paced to avoid GI intolerance.

Regular check-ins allow dosage adjustments based on response and tolerance. This includes regular blood tests to monitor blood sugar, kidney and liver function, and other vital markers, plus a thorough review of health history focusing on conditions like pancreatitis or thyroid disease, so the plan can be adjusted in a timely way.

While the medication reduces appetite, what you eat still matters. In clinical trials, participants followed reduced-calorie diets and increased physical activity alongside treatment – the injection works best as a tool within a broader behavioral framework, not a sole replacement.

doctor advice who cannot get semaglutide
  • Blood pressure reduction, lowering the risk of hypertension and heart-related complications.
  • Better lipid profile: reduced LDL (bad cholesterol) and increased HDL (good cholesterol).
  • Alleviation of fatty liver disease (NAFLD), common in individuals with obesity.
  • Lower risk of heart disease by addressing obesity, high blood pressure, and poor lipid profiles.
  • Less mental stress about food: you feel satisfied with smaller portions and fewer cravings.
  • More energy without caffeine: stable blood sugar means fewer crashes and better focus.
  • Easier to manage social situations: you can enjoy meals out without guilt or overeating.
  • Improved consistency: when your body is in balance, healthy habits become easier to sustain.
Trend DietsSlimming Medicine
Restriction
Often extreme (keto, fasting, juice)Minimal, focused on hunger regulation
Mental burnoutHigh: difficult to maintainLow: supports consistent lifestyle changes
Nutritional balanceMay lack key nutrientsEncourages balanced, realistic eating
Long-term resultsOften regain after stoppingDesigned for sustainable fat loss

Focusing solely on body weight can be misleading – it’s easy to get discouraged if the number doesn’t move quickly, even when your body is making important changes underneath.

  • Body composition tells the real story: losing fat and preserving (or gaining) lean muscle matters more than the number on the scale.
  • Better energy and reduced fatigue.
  • Improved digestion and less bloating.
  • Stronger mental focus and mood.
  • Deeper, more restful sleep.
  • More confidence in your routine.

Cost is one of the most common questions when comparing options. Current H.U.M. Clinic dose-based pricing:

DosePrice (THB)
2.5 mg13,900
5 mg16,900
7.5 mg19,900
10 mg22,900
12.5 mg25,900
15 mg28,900
DosePrice (THB)
0.25 mg9,900
0.5 mg11,900
1 mg13,900
1.7 mg16,900
2.4 mg18,900

A doctor consultation fee of 1,500 THB per visit applies. H.U.M. Clinic has two Bangkok locations: Exchange Tower (Asok / Sukhumvit) and Thonglor (Hotel Nikko). Prices are subject to change; contact the clinic directly to confirm current rates before booking.

Semaglutide, tirzepatide, retatrutide, and liraglutide are different medications with different mechanisms, dosing schedules, and clinical profiles. Though different, they share a meaningful evidence base and a track record of results when used correctly under medical supervision.

A good program includes body composition scans (to track fat vs. muscle), lab work to identify hormonal or metabolic imbalances, personalized guidance on medication and nutrition, and ongoing check-ins to adjust and support your routine. At H.U.M. Clinic, our weight loss programs are supervised by specialist physicians, supported by comprehensive health check-ups, and structured around ongoing monitoring to help you achieve lasting results.

Why choose H.U.M. Clinic: authenticity guaranteed (all medications sourced directly from reputable pharmaceutical companies, Thai FDA approved, meeting CODEX GMP and ISO 9001:2015 quality standards), optimal storage conditions with specialized refrigeration, expert guidance from healthcare professionals, and a convenient, professional experience from consultation to prescription.

doctor giving a consultation about liraglutide medication

What is the best injection for weight loss in Thailand?

There’s no universal answer. Tirzepatide (Mounjaro) has demonstrated the strongest average weight loss in clinical trials, with up to 22.5% body weight reduction at 72 weeks in the phase 3 SURMOUNT-1 study. Suitability depends on health history, BMI, and medical assessment – a consultation at a licensed Bangkok clinic is the only reliable way to determine the right option.

How does Mounjaro work for weight loss?

Mounjaro (tirzepatide) activates two receptor types simultaneously – GLP-1 and GIP – both incretin hormones involved in appetite regulation, gastric emptying, and blood sugar control. Activating both pathways produces stronger appetite suppression than GLP-1 alone.

What are the most common weight loss injection side effects, and are they anything to worry about?

The most frequently reported side effects are gastrointestinal: nausea, loose stools, constipation, and occasional vomiting. These are most common during dose escalation and generally ease once the body adjusts. Most side effects are mild; your doctor will guide you throughout treatment.

How soon can I expect to see results with a weight loss injection?

Appetite changes typically begin within 1-2 weeks. Visible weight changes emerge within 4-8 weeks. Clinically meaningful results accumulate over 3-6 months, with maximum results often after consistent use over 6-12 months alongside dietary and behavioral changes.

Can I combine weight loss injections with diet and exercise?

Yes. Injections work best when combined with healthy eating and regular physical activity – they are a tool within a broader behavioral framework, not a sole replacement.

What happens after I stop taking weight loss injections?

Appetite may increase again. Gradual tapering combined with lifestyle adjustments helps maintain results; weight often returns without ongoing lifestyle changes in place.

What happens if I miss a dose of my weight loss injection?

Take it as soon as you remember. If it is almost time for your next dose, skip the missed one – do not double up. Always follow your healthcare provider’s specific instructions.

How do I store my weight loss injection pen?

Unopened pens such as Saxenda should be stored in a refrigerator, usually between 2C and 8C. Avoid freezing the pen.

Book a weight loss injection consultation in Bangkok at H.U.M. Clinic today for a personalized health evaluation and treatment plan tailored to your specific goals.